Related Experiment Video
Updated: Jun 16, 2026
12:13
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Dissecting the dynamics of serum prostate-specific antigen
1Laboratory Medicine 113, VA Medical Center, Durham, NC 27705, USA.
American Journal of Clinical Pathology
|January 23, 2010
Summary
Serum prostate-specific antigen (PSA) levels before prostate cancer diagnosis follow a dual exponential model. This model differentiates between benign and malignant prostate tissue contributions to PSA dynamics.
Area of Science:
- Urology
- Biomedical Engineering
- Oncology
Background:
- Serum prostate-specific antigen (PSA) is a key biomarker for prostate cancer.
- Understanding PSA dynamics is crucial for early and accurate diagnosis.
Purpose of the Study:
- To model the temporal changes in serum PSA levels before prostate cancer diagnosis.
- To investigate the association between PSA kinetics and prostate tissue characteristics.
Main Methods:
- Analysis of over 800 serum PSA values from 119 American Veterans prior to diagnosis.
- Application of a dual exponential function model to describe PSA trends over time.
Main Results:
- Serum PSA values exhibit a biphasic exponential rise, comprising slow and fast components.
- The slow component's velocity correlates with benign prostate tissue volume.
- Both amplitude and velocity of the fast component are significantly associated with tumor volume.
Conclusions:
- The developed dual exponential model elucidates the contributions of benign and malignant tissues to PSA dynamics.
- PSA levels and velocity at diagnosis reflect a combination of these slow and fast components.
- This model offers insights into the biological basis of PSA changes in prostate cancer.
